van Loon Harald J, Vriens Menno R, Fluit Ad C, Troelstra Annet, van der Werken Christiaan, Verhoef Jan, Bonten Marc J M
Department of Surgery, Eijkman-Winkler Institute for Microbiology, Infectious Disease and Inflammation, University Medical Center Utrecht, Heidelberglaan 100, PO Box 3508 GA, Utrecht, The Netherlands.
Am J Respir Crit Care Med. 2005 Mar 1;171(5):480-7. doi: 10.1164/rccm.200401-070OC. Epub 2004 Oct 29.
To attain a better understanding of antibiotic cycling and its effects on the epidemiology of antibiotic resistance in gram-negative microorganisms, two different antibiotic classes (quinolone and beta-lactam) were cycled during four 4-month periods in a surgical intensive care unit. Respiratory aspirates and rectal swabs were obtained and DNA fingerprinting was performed. Primary endpoint of the study was the acquisition rate with gram-negative bacteria resistant to the antibiotic of choice during each cycle. Secondary endpoints were changes in endemic prevalence of resistant bacteria and the relative importance of cross-transmission. In all, 388 patients were included and 2,520 cultures analyzed. Adherence to antibiotic protocol was 96%. Overall antibiotic use increased with 24%. Acquisition rates with resistant bacteria were highest during levofloxacin exposure (relative risk [RR] 3.2; 95% confidence interval [CI]: 1.4-7.1) and piperacillin/tazobactam exposure (RR 2.4; 95% CI 1.2-4.8). The relative importance of cross-transmission decreased during the study. For individual patients, treatment with levofloxacin was the only independent risk factor for acquisition of levofloxacin-resistant bacteria (hazard ratio 12.6; 95% CI 3.8-41.6). Potential for selection of antibiotic-resistant gram-negative bacteria during periods of homogeneous exposure increased from cefpirome to piperacillin/tazobactam to levofloxacin. Cycling of homogeneous antibiotic exposure is unlikely to control the emergence of gram-negative antimicrobial resistance in intensive care units.
为了更好地理解抗生素循环及其对革兰氏阴性微生物抗生素耐药性流行病学的影响,在一个外科重症监护病房的四个4个月周期内,对两类不同的抗生素(喹诺酮类和β-内酰胺类)进行了循环使用。获取了呼吸道吸出物和直肠拭子并进行了DNA指纹分析。该研究的主要终点是每个周期中对所选抗生素耐药的革兰氏阴性菌的获得率。次要终点是耐药菌的地方流行率变化以及交叉传播的相对重要性。总共纳入了388例患者,分析了2520份培养物。抗生素方案的依从率为96%。总体抗生素使用量增加了24%。在左氧氟沙星暴露期间(相对风险[RR] 3.2;95%置信区间[CI]:1.4 - 7.1)和哌拉西林/他唑巴坦暴露期间(RR 2.4;95% CI 1.2 - 4.8),耐药菌的获得率最高。在研究期间,交叉传播的相对重要性降低。对于个体患者,使用左氧氟沙星治疗是获得耐左氧氟沙星细菌的唯一独立危险因素(风险比12.6;95% CI 3.8 - 41.6)。在同质化暴露期间,从头孢匹罗到哌拉西林/他唑巴坦再到左氧氟沙星,选择耐抗生素革兰氏阴性菌的可能性增加。在重症监护病房中,同质化抗生素暴露的循环不太可能控制革兰氏阴性菌耐药性的出现。